Logo image of SPRC

SCISPARC LTD (SPRC) Stock Price, Quote, News and Overview

NASDAQ:SPRC - Nasdaq - IL0010951403 - Common Stock - Currency: USD

4.51  -0.4 (-8.15%)

After market: 4.82 +0.31 (+6.87%)

SPRC Quote, Performance and Key Statistics

SCISPARC LTD

NASDAQ:SPRC (8/15/2025, 8:00:02 PM)

After market: 4.82 +0.31 (+6.87%)

4.51

-0.4 (-8.15%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High37.59
52 Week Low4.14
Market Cap2.39M
Shares530.00K
Float530.00K
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO12-22 2021-12-22


SPRC short term performance overview.The bars show the price performance of SPRC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40 -50

SPRC long term performance overview.The bars show the price performance of SPRC in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of SPRC is 4.51 USD. In the past month the price decreased by -40.19%. In the past year, price decreased by -41.96%.

SCISPARC LTD / SPRC Daily stock chart

SPRC Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 43.42 664.58B
JNJ JOHNSON & JOHNSON 17.66 425.41B
AZN ASTRAZENECA PLC-SPONS ADR 17.83 245.46B
NVS NOVARTIS AG-SPONSORED ADR 14.04 240.45B
NVO NOVO-NORDISK A/S-SPONS ADR 13.4 232.88B
MRK MERCK & CO. INC. 10.94 211.45B
PFE PFIZER INC 7.42 142.93B
SNY SANOFI-ADR 11.21 121.39B
BMY BRISTOL-MYERS SQUIBB CO 7.2 98.58B
GSK GSK PLC-SPON ADR 8.67 79.42B
ZTS ZOETIS INC 24.78 68.61B
TAK TAKEDA PHARMACEUTIC-SP ADR 50 47.37B

About SPRC

Company Profile

SPRC logo image SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.

Company Info

SCISPARC LTD

20 Raul Wallenberg Street, Tower A

TEL AVIV-YAFO IL

Employees: 3

SPRC Company Website

SPRC Investor Relations

Phone: 97236103100

SCISPARC LTD / SPRC FAQ

What is the stock price of SCISPARC LTD today?

The current stock price of SPRC is 4.51 USD. The price decreased by -8.15% in the last trading session.


What is the ticker symbol for SCISPARC LTD stock?

The exchange symbol of SCISPARC LTD is SPRC and it is listed on the Nasdaq exchange.


On which exchange is SPRC stock listed?

SPRC stock is listed on the Nasdaq exchange.


What is SCISPARC LTD worth?

SCISPARC LTD (SPRC) has a market capitalization of 2.39M USD. This makes SPRC a Nano Cap stock.


How many employees does SCISPARC LTD have?

SCISPARC LTD (SPRC) currently has 3 employees.


What are the support and resistance levels for SCISPARC LTD (SPRC) stock?

SCISPARC LTD (SPRC) has a resistance level at 6.18. Check the full technical report for a detailed analysis of SPRC support and resistance levels.


Should I buy SCISPARC LTD (SPRC) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does SCISPARC LTD (SPRC) stock pay dividends?

SPRC does not pay a dividend.


What is the Price/Earnings (PE) ratio of SCISPARC LTD (SPRC)?

SCISPARC LTD (SPRC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-16.9).


SPRC Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

SPRC Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to SPRC. The financial health of SPRC is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SPRC Financial Highlights

Over the last trailing twelve months SPRC reported a non-GAAP Earnings per Share(EPS) of -16.9. The EPS increased by 36.01% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -49.87%
ROE -63.28%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-170.07%
Sales Q2Q%N/A
EPS 1Y (TTM)36.01%
Revenue 1Y (TTM)-54.64%

SPRC Ownership and Analysts


Ownership
Inst Owners1.1%
Ins Owners0%
Short Float %N/A
Short Ratio0.1
Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A